Lineage Cell Therapeutics Inc (NY: LCTX )
0.8921
-0.0162
(-1.78%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 22, 2024
Add to My Watchlist
All News about Lineage Cell Therapeutics Inc
![](https://mms.businesswire.com/media/20240813574683/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240808545425/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Lineage Cell Therapeutics: Q4 Earnings Insights
March 07, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
A Preview Of Lineage Cell Therapeutics's Earnings
March 06, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240801608382/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240702244492/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240530288523/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240521738549/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240509142533/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240502738426/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240506017390/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240430502008/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240429858960/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
Lineage Announces Changes to Board of Directors
April 29, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240401267142/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240318962645/en/2069541/5/CDRFlogo_2012.jpg)
![](https://mms.businesswire.com/media/20240307502626/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240313697648/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240311914768/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240229203493/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240213332150/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240209732533/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20240206000006/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
February 01, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/03/image16.jpg?width=1200&height=800&fit=crop)
Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying
January 03, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.